Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experience.

Christopher CroninShahid IqbalAbdul R FarooqPauline O'DeaLouise BurkeSéamus O'ReillyDeirdre O'MahonyDerek G PowerRichard M BamburyDearbhaile C Collins

Published in: Lung cancer management (2023)

High rates of disease recurrence and treatment-associated morbidity were observed in patients receiving adjuvant chemotherapy for NSCLC. Novel therapeutic strategies are required to improve outcomes in this population.

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
oxidative stress
type diabetes
metabolic syndrome
skeletal muscle
weight loss
smoking cessation
epidermal growth factor receptor
free survival